glp-1 r retatrutide vs Semaglutide and Tirzepatide: GLP-3 Facts explained RETATRUTIDE: A Medication for Diabetes

Contact your healthcare provider within 24 hours if you develop a widespread rash, persistent itching affecting multiple body areas, or skin reactions accompanied by fever, joint pain, or general malaise

At 48 weeks, weight loss was dose-dependent: the 12 mg group achieved approximately 24.2% mean weight loss, which was meaningfully higher than the approximately 15% reported for semaglutide 2.4 mg in the STEP 1 trial and approximately 20-22% for tirzepatide in the SURMOUNT trials

Long-term use: Obesity is chronic

This has led researchers to investigate medications that modulate these systems, including the glucagon-like peptide-1 (GLP-1) receptor agonists originally developed for type 2 diabetes and obesity management

PlexusDx does not sell it

The inhibitory effect is presumably mediated indirectly through somatostatin secretion, but a direct effect cannot be completely excluded